$0.378000
0.1675.32%
After Hours: Mar 5, 8:00 AM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Antibe Therapeutics in recent months.
Browse guidance and forecast on all stocks.